Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2 | P00734 | 1/20 | 0.37 |
| ▸ | CPN1 | P15169 | 2/20 | 0.37 |
| ▸ | CPB2 | Q96IY4 | 2/20 | 0.37 |
| ▸ | NOS3 | P29474 | 1/20 | 0.33 |
| ▸ | NOS1 | P29475 | 1/20 | 0.33 |
| ▸ | NOS2 | P35228 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6401326 | 0.84 | CPN1 (0.36) | F2CPN1CPB2NOS3NOS1 | |
| SCHEMBL24138717 | 0.81 | F2 (0.37) | F2CPN1CPB2NOS3NOS1 | |
| SCHEMBL13804441 | 0.80 | CPN1 (0.55) | F2CPN1CPB2 | |
| SCHEMBL13804436 | 0.79 | CPN1 (0.49) | F2CPN1CPB2 | |
| SCHEMBL20756331 | 0.76 | CHRNB2 (0.38) | CPN1CPB2 | |
| SCHEMBL6394276 | 0.73 | CPN1 (0.44) | F2CPN1CPB2 | |
| SCHEMBL24292512 | 0.72 | F2 (0.42) | F2 | |
| SCHEMBL15373046 | 0.72 | — | — | |
| SCHEMBL24762370 | 0.68 | F2 (0.44) | F2CPN1CPB2 | |
| SCHEMBL15369573 | 0.68 | F2 (0.39) | F2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10815238-B2 | Antimicrobial compounds and methods of making and using the same | BioVersys AG (CH) | 2020-10-27 | — | — | US | disclosed |
| US-20190284190-A1 | ANTIMICROBIAL COMPOUNDS AND METHODS OF MAKING AND USING THE SAME | BioVersys AG (CH) | 2019-09-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190284190-A1 | ANTIMICROBIAL COMPOUNDS AND METHODS OF MAKING AND USING THE SAME | MPO, LPO, CAT | F2 1772/4885CPN1 1276/4885CPB2 1591/4885 |
| US-10815238-B2 | Antimicrobial compounds and methods of making and using the same | MPO, LPO, CAT | F2 1772/4885CPN1 1276/4885CPB2 1591/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.